Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts
Jing Qian, Frank J. Wolters, Alexa S. Beiser, et al.
PLoS Medicine (2017) Vol. 14, Iss. 3, pp. e1002254-e1002254
Open Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Alzheimer's disease
José Arguedas López, Hector M. González, Gabriel C. Léger
Handbook of clinical neurology (2019), pp. 231-255
Closed Access | Times Cited: 624
2024 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3708-3821
Open Access | Times Cited: 561
The Rotterdam Study: 2018 update on objectives, design and main results
M. Arfan Ikram, Guy Brusselle, Sarwa Darwish Murad, et al.
European Journal of Epidemiology (2017) Vol. 32, Iss. 9, pp. 807-850
Open Access | Times Cited: 416
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
Lisa Vermunt, Sietske A.M. Sikkes, Ardo van den Hout, et al.
Alzheimer s & Dementia (2019) Vol. 15, Iss. 7, pp. 888-898
Open Access | Times Cited: 392
State of the science on mild cognitive impairment (MCI)
Nicole D. Anderson
CNS Spectrums (2019) Vol. 24, Iss. 1, pp. 78-87
Open Access | Times Cited: 376
APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics
Mohammed Amir Husain, Benoît Laurent, Mélanie Plourde
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 221
The “rights” of precision drug development for Alzheimer’s disease
Jeffrey L. Cummings, Howard Feldman, Philip Scheltens
Alzheimer s Research & Therapy (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 203
Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes
Matthew P. Pase, Alexa S. Beiser, Jayandra J. Himali, et al.
JAMA Neurology (2019) Vol. 76, Iss. 5, pp. 598-598
Open Access | Times Cited: 172
The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study
Amin Gharbi‐Meliani, Aline Dugravot, Séverine Sabia, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 110
Alternative splicing in neurodegenerative disease and the promise of RNA therapies
David Nikom, Sika Zheng
Nature reviews. Neuroscience (2023) Vol. 24, Iss. 8, pp. 457-473
Closed Access | Times Cited: 77
Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders
Аnna Morozova, Yana Zorkina, Olga Abramova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1217-1217
Open Access | Times Cited: 70
Multifaceted roles of APOE in Alzheimer disease
Rosemary J. Jackson, Bradley T. Hyman, Alberto Serrano‐Pozo
Nature Reviews Neurology (2024) Vol. 20, Iss. 8, pp. 457-474
Closed Access | Times Cited: 31
Lifetime risk and projected burden of dementia
Michael Fang, Jiaqi Hu, Jordan Weiss, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 5
Multifactorial Hypothesis and Multi-Targets for Alzheimer’s Disease
Cheng‐Xin Gong, Fei Liu, Khalid Iqbal
Journal of Alzheimer s Disease (2018) Vol. 64, Iss. s1, pp. S107-S117
Closed Access | Times Cited: 145
The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer’s Disease
Courtney M. Kloske, Donna M. Wilcock
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 129
The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease
Cristina López López, Pierre N. Tariot, Angelika Caputo, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2019) Vol. 5, Iss. 1, pp. 216-227
Open Access | Times Cited: 98
Meat consumption and risk of incident dementia: cohort study of 493,888 UK Biobank participants
Huifeng Zhang, Darren C. Greenwood, Harvey A. Risch, et al.
American Journal of Clinical Nutrition (2021) Vol. 114, Iss. 1, pp. 175-184
Open Access | Times Cited: 98
Absolute 10-year risk of dementia by age, sex and APOE genotype: a population-based cohort study
Katrine Laura Rasmussen, Anne Tybjærg‐Hansen, Børge G. Nordestgaard, et al.
Canadian Medical Association Journal (2018) Vol. 190, Iss. 35, pp. E1033-E1041
Open Access | Times Cited: 80
Dementia and aging populations—A global priority for contextualized research and health policy
Carol Brayne, Bruce L. Miller
PLoS Medicine (2017) Vol. 14, Iss. 3, pp. e1002275-e1002275
Open Access | Times Cited: 79
Sphingolipids in neurodegeneration (with focus on ceramide and S1P)
Guanghu Wang, Erhard Bieberich
Advances in Biological Regulation (2018) Vol. 70, pp. 51-64
Open Access | Times Cited: 72
Polygenic hazard scores in preclinical Alzheimer disease
Chin Hong Tan, Bradley T. Hyman, Jacinth J. X. Tan, et al.
Annals of Neurology (2017) Vol. 82, Iss. 3, pp. 484-488
Open Access | Times Cited: 63
APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia
Saira Saeed Mirza, Usman Saeed, Jo Knight, et al.
Neurology (2019) Vol. 93, Iss. 19
Open Access | Times Cited: 56
Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration
Nicolai Franzmeier, Marc Suárez‐Calvet, Lukas Frontzkowski, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 54
Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia
Xue‐Ning Shen, Jieqiong Li, Hui‐Fu Wang, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 51
Identification of epigenome-wide DNA methylation differences between carriers of APOE ε4 and APOE ε2 alleles
Rosie M. Walker, Kadi Vaher, Mairead L. Bermingham, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top